Intensive Blood-Pressure Control in Patients with Type 2 Diabetes.

Yufang Bi, Mian Li, Yan Liu, Tingzhi Li, Jieli Lu, Peng Duan, Fengmei Xu, Qijuan Dong, Ailiang Wang, Tiange Wang, Ruizhi Zheng, Yuhong Chen, Min Xu, Xiaohu Wang, Xinhuan Zhang

March 2025

Synopsis of Social media discussions

Many discussions reflect on specific findings from the article, such as the notable reduction in major cardiovascular events in patients with a target systolic blood pressure of less than 120 mm Hg compared to 140 mm Hg. Phrases like 'old blood pressure targets are no longer acceptable' and 'evidence continues to mount' convey a sense of urgency and transformation in how these conditions might be treated moving forward. The tone across the posts is generally positive and supportive, showcasing a forward-thinking attitude toward the implications of this research.

A
Agreement
 Strong agreement

The majority of discussions indicate strong support for the findings presented in the publication, highlighting a consensus on the benefits of intensive blood pressure control.

I
Interest
 High level of interest

Participants express high interest in the study, frequently referencing its implications for current medical practices.

E
Engagement
 Moderate level of engagement

While many posts summarize findings, a few delve into specific outcomes and potential changes to clinical guidelines, indicating moderate engagement.

I
Impact
 High level of impact

There is a widespread belief that these findings could significantly alter treatment protocols for managing blood pressure in diabetic patients.

Social Mentions

YouTube

2 Videos

Bluesky

12 Posts

Facebook

4 Posts

Twitter

237 Posts

Blogs

5 Articles

News

24 Articles

Reddit

2 Posts

Metrics

Video Views

596

Total Likes

454

Extended Reach

2,119,340

Social Features

286

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Examining the Effects of Climate Change on Marine Life

Examining the Effects of Climate Change on Marine Life

This video explores how climate change impacts marine ecosystems. We'll dive into the changes in ocean temperature, acidity, and effects on biodiversity, highlighting recent research findings and their implications for oceanic health. Join us to understand the urgent challenges facing our oceans.

Rapid Rounding | MedEd

May 19, 2025

350 views

New Insights on Hypertension Management and Atrial Fibrillation

New Insights on Hypertension Management and Atrial Fibrillation

This week, John Mandrola MD discusses the latest hypertension guidelines targeting systolic blood pressure for type 2 diabetes patients, highlighting intensive treatment's impact on cardiovascular events. Also covered are key updates on pulsed field ablation and ultraprocessed foods.

Medscape

August 15, 2025

246 views

  • Azalea Voices
    @Lea_voices (Twitter)

    RT @EricTopol: New @NEJM and #AHA24 A large randomized trial in people with Type 2 diabetes showed intensive BP lowering (systolic < 120 m…
    view full post

    September 8, 2025

    74

  • Geneva Grace
    @Geneva___Grace (Twitter)

    RT @_Anesthesiology: Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Med…
    view full post

    August 17, 2025

    9

  • Omar Andablo Marquez
    @omar_and24 (Twitter)

    RT @_Anesthesiology: Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Med…
    view full post

    August 3, 2025

    9

  • BCM Department of Anesthesiology
    @BCMAnesthesia (Twitter)

    RT @_Anesthesiology: Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Med…
    view full post

    August 2, 2025

    9

  • MJ Colomina
    @mjcolomina (Twitter)

    RT @_Anesthesiology: Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Med…
    view full post

    August 2, 2025

    9

  • betül kozanhan
    @betulkozanhan (Twitter)

    RT @_Anesthesiology: Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Med…
    view full post

    August 1, 2025

    9

  • Fernando Rios B.
    @fernandorios07 (Twitter)

    RT @_Anesthesiology: Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Med…
    view full post

    August 1, 2025

    9

  • happy anesth
    @kmyk08315265 (Twitter)

    RT @_Anesthesiology: Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Med…
    view full post

    August 1, 2025

    9

  • Renato Herrera
    @RenatoJHG (Twitter)

    RT @_Anesthesiology: Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Med…
    view full post

    August 1, 2025

    9

  • waqar dahri
    @Dahri85Waqar (Twitter)

    RT @_Anesthesiology: Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Med…
    view full post

    August 1, 2025

    9

  • Anesthesiology
    @_Anesthesiology (Twitter)

    Read a summary of "Intensive blood-pressure control in patients with type 2 diabetes," in the August 2025 Science, Medicine, and the Anesthesiologist: https://t.co/JavW4BESFk https://t.co/ZHxX1ScyZT
    view full post

    August 1, 2025

    20

    9

  • @MARTINSVEL
    @MARTINSVEL (Twitter)

    RT @TGijonConde: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine @SEHLELHA140_90 @AMARE…
    view full post

    July 26, 2025

    3

  • AMAREVA Riesgo Vascular
    @AMAREVA_Madrid (Twitter)

    RT @TGijonConde: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine @SEHLELHA140_90 @AMARE…
    view full post

    July 26, 2025

    3

  • SEH-LELHA
    @SEHLELHA140_90 (Twitter)

    RT @TGijonConde: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine @SEHLELHA140_90 @AMARE…
    view full post

    July 26, 2025

    3

  • Teresa Gijon Conde
    @TGijonConde (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine @SEHLELHA140_90 @AMAREVA_Madrid https://t.co/I7IzdIopMd https://t.co/qylnzfTfeB
    view full post

    July 26, 2025

    6

    3

  • Cecelia Care ♥️
    @ceceliacare.bsky.social (Bluesky)

    "Intensive Blood-Pressure Control in Patients with Type 2 Diabetes" #Health #Healthcare #ElderCare #MedSky
    view full post

    July 3, 2025

  • mocchi
    @mocchi_ym (Twitter)

    RT @irjpnmEqqEUJraX: BPROAD試験 NEJM2024 中国2型DM合併高血圧患者12,821例。標準降圧(目標SBP 140)に比し厳格降圧(120mmHg)で MACEのHR 0.79へ低下、主に脳卒中の減少。CKD発症・進行に有意差なし。 https…
    view full post

    June 26, 2025

    2

  • redGDPS Diabetes
    @redGDPS (Twitter)

    Full text links https://t.co/kQ0m2ICP5s https://t.co/4WrBzp2qwf
    view full post

    June 19, 2025

  • redGDPS Diabetes
    @redGDPS (Twitter)

    Acceso bibliografía @PubMedOnline Intensive Blood-Pressure Control in Patients with Type 2 Diabetes Yufang Bi et al. N Engl J Med. 2025. https://t.co/QHzVIhFYlF https://t.co/HNCbQllxLb
    view full post

    June 19, 2025

  • Mónica Piñeiro
    @monicapiii (Twitter)

    NEJM at AHA — Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/jewjNRvMEZ
    view full post

    June 2, 2025

  • 常に戦力外の保健室長
    @HironoriMayuki (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • Dr Yoann Kiavué
    @Drykcardio (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • david eckley
    @galalaxyquest (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • Omar Shazly
    @Shazlymed (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • andres
    @palacioendocrin (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • ong beng hooi
    @ongbenghooi1 (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • D.#dwards
    @P33RL3SS (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • Dr Tom Butler
    @drtom_butler (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • Colleen Griffith
    @Griffith17431 (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • Michael Mindrum, MD
    @MichaelMindrum (Twitter)

    RT @BradStanfieldMD: Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure…
    view full post

    May 30, 2025

    10

  • Lipid Legends
    @lipidlegends (Twitter)

    Nach 4,2 Jahren zeigte sich: Die intensiv behandelte Gruppe hatte signifikant weniger Herzinfarkte, Schlaganfälle und Todesfälle durch Herz-Kreislauf-Erkrankungen – bei vergleichbarem Sicherheitsprofil. https://t.co/Y43R8ig7hH https://t.co/U9KVP77MId
    view full post

    May 30, 2025

  • Lipid Legends
    @lipidlegends (Twitter)

    Eine aktuelle Studie im New England Journal of Medicine („Intensive Blood-Pressure Control in Patients with Type 2 Diabetes“) zeigt: https://t.co/rpznJz1lDe
    view full post

    May 30, 2025

  • Dr Brad Stanfield
    @BradStanfieldMD (Twitter)

    Study link: https://t.co/TPH8wCTa45
    view full post

    May 29, 2025

    3

  • Dr Brad Stanfield
    @BradStanfieldMD (Twitter)

    Old blood pressure targets are no longer acceptable. Evidence continues to mount for a lower systolic blood pressure target of 120. New study published in the NEJM titled: "Intensive Blood-Pressure Control in Patients with Type 2 Diabetes" The BPROAD study determined suitable https://t.co/bkAfz1siFe
    view full post

    May 29, 2025

    73

    10

  • Mounir Basalus (Ⲃⲁⲥⲓⲗⲓⲟⲥ)
    @Basalus (Twitter)

    8/
    view full post

    May 29, 2025

  • @CKD_ce
    @ckd_ce (Twitter)

    16) BPROAD: Strong #CV benefit, no renal harm
    view full post

    May 28, 2025

    2

  • cardio-met
    @cardiomet_CE (Twitter)

    16) BPROAD: Strong #CV benefit, no renal harm
    view full post

    May 28, 2025

  • am namu
    @umetotetsu (Twitter)

    「2型糖尿病でSBP<120 vs SBP<140とすると、前者は主要な心血管イベントの発生率を有意に低下/一方で症候性低血圧や高カリウム血症のリスクは増加」 外来でついまぁちょい高いっすけどもう少し様子見てみましょうか〜とか言っちゃうことあるけど, もっと厳格にせないかんかなぁhttps://t.co/QNQxIYoGez
    view full post

    May 23, 2025

  • Jiyeon
    @grantinlight (Twitter)

    RT @EricTopol: New @NEJM and #AHA24 A large randomized trial in people with Type 2 diabetes showed intensive BP lowering (systolic < 120 m…
    view full post

    May 17, 2025

    74

  • Zurko
    @Zurko44057468 (Twitter)

    RT @AMAREVA_Madrid: Nuevo comentario del ensayo clínico BPROAD sobre de la Dra. Adriana Puente García https://t.co/V5WC8CdxWv https://t.co…
    view full post

    May 11, 2025

    7

  • Marta Guillan
    @Martaguillan (Twitter)

    RT @AMAREVA_Madrid: Nuevo comentario del ensayo clínico BPROAD sobre de la Dra. Adriana Puente García https://t.co/V5WC8CdxWv https://t.co…
    view full post

    May 7, 2025

    7

  • SebasGMadrona
    @SebasGMadrona (Twitter)

    RT @AMAREVA_Madrid: Nuevo comentario del ensayo clínico BPROAD sobre de la Dra. Adriana Puente García https://t.co/V5WC8CdxWv https://t.co…
    view full post

    May 6, 2025

    7

  • Ramón Jesús Miranda, MD
    @rjmh_md (Twitter)

    RT @AMAREVA_Madrid: Nuevo comentario del ensayo clínico BPROAD sobre de la Dra. Adriana Puente García https://t.co/V5WC8CdxWv https://t.co…
    view full post

    May 6, 2025

    7

  • esther rubio
    @draerubio (Twitter)

    RT @AMAREVA_Madrid: Nuevo comentario del ensayo clínico BPROAD sobre de la Dra. Adriana Puente García https://t.co/V5WC8CdxWv https://t.co…
    view full post

    May 6, 2025

    7

  • BEATRIZ LOPEZ URIARTE
    @BEATRIZLOPEZUR1 (Twitter)

    RT @AMAREVA_Madrid: Nuevo comentario del ensayo clínico BPROAD sobre de la Dra. Adriana Puente García https://t.co/V5WC8CdxWv https://t.co…
    view full post

    May 6, 2025

    7

  • Teresa Gijon Conde
    @TGijonConde (Twitter)

    RT @AMAREVA_Madrid: Nuevo comentario del ensayo clínico BPROAD sobre de la Dra. Adriana Puente García https://t.co/V5WC8CdxWv https://t.co…
    view full post

    May 6, 2025

    7

  • AMAREVA Riesgo Vascular
    @AMAREVA_Madrid (Twitter)

    Nuevo comentario del ensayo clínico BPROAD sobre de la Dra. Adriana Puente García https://t.co/V5WC8CdxWv https://t.co/at2xZBSLP6
    view full post

    May 6, 2025

    9

    7

  • Vietnam Atherosclerosis Society (VAS)
    @HOATRAN82820145 (Twitter)

    RT @HOATRAN82820145: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes https://t.co/BEUMFiGfMF
    view full post

    May 2, 2025

    1

  • Dr. Claire Pomeroy
    @clairepomeroy (Twitter)

    Intensive blood-pressure control in patients with type 2 diabetes – Study finds the incidence of major cardiovascular events was significantly ⬇️ w/ treatment targeting a systolic blood pressure <120 mm Hg vs. standard treatment targeting a BP < 140 mm Hg. https://t.co/wQ2KOl0k4S https://t.co/zQYYBHAIXV
    view full post

    April 29, 2025

  • Icc
    @Iccsardana (Twitter)

    RT @mmacia25: Estudio que confirma la necesidad de ser mas exigente en el control de la HTA en pacientes con DM2. Intensive Blood-Pressure…
    view full post

    April 27, 2025

    15

  • Dr Mukesh Palsania
    @m_palsania (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    April 21, 2025

    55

  • Zacchy
    @bolton_lovnZC (Twitter)

    RT @Tak0123: 今週のNEJMに2型糖尿病患者の降圧目標に関するRCTが 収縮期血圧を120未満に厳格に管理すると、140未満に抑える標準治療と比べて、心血管イベント（脳卒中、心筋梗塞、心不全、心血管死）の複合アウトカムが有意に低下した（1.65 vs 2.09/1…
    view full post

    April 19, 2025

    1

  • S.E.N. Nefrología
    @SENefrologia (Twitter)

    RT @redGDPS:
    view full post

    April 10, 2025

    3

  • Juanmarcosgg
    @juanmarcosgg (Twitter)

    RT @redGDPS:
    view full post

    April 9, 2025

    3

  • Aeseerre.....
    @asrzgz1 (Twitter)

    RT @redGDPS:
    view full post

    April 8, 2025

    3

  • redGDPS Diabetes
    @redGDPS (Twitter)


    view full post

    April 8, 2025

    10

    3

  • Public Health Media Monitoring Kumasan
    @shimadas0723 (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/uzXM0p2Nsi
    view full post

    April 8, 2025

  • SEMERGEN | Médicos de AP #SEMERGEN25
    @SEMERGENap (Twitter)

    #DM2
    view full post

    April 8, 2025

  • Arturo Aleman
    @ElArturoAleman (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 7, 2025

    27

  • SVEDYN
    @SVEDYN_ (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/A7ObUaaP1C
    view full post

    April 7, 2025

    2

  • Sebastián Tenorio Vargas
    @SebasTenorio (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 7, 2025

    27

  • 旅人 tabito
    @tabibito250 (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/j4dJy7kx63
    view full post

    April 7, 2025

    1

  • Ikudayisi Ekiti Johnson Olawale
    @IkudayisiJ (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 7, 2025

    27

  • JohnVyselaarCardio
    @johnrvcardio (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 7, 2025

    27

  • Nefrosaurus Saurus
    @Nefrosaurus (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 7, 2025

    27

  • Niyi
    @NiyiMk (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 7, 2025

    27

  • ALKINDY Abdulrhman
    @Abdul_alkindy (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 7, 2025

    27

  • Ken Tait
    @bromleydiabetic (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 7, 2025

    27

  • octavio
    @dontavo66 (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • EOLO MORANDI JR.
    @eolojr (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Resham Gurung
    @Resham_LG (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Edith WK Chow
    @EWKChow (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • diacavan
    @diacavan (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • CardioAcademic
    @CardioAcademic (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Akachukwu Nwakoby
    @AkachukwuNwako1 (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Rafael Radaeli
    @rfradaeli (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • CHN390 MD
    @cihan390 (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • McMaster Heart Function Education
    @MacHeartFailure (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Hany Ragy
    @Hragy (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • shaffy
    @shaffy8585 (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Arturo
    @cardiogeriatra (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Khalid Minhas, MD FACC
    @minhaskh (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Colleen Griffith
    @Griffith17431 (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Harriette Van Spall, MD MPH
    @hvanspall (Twitter)

    RT @docmaltese: In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major…
    view full post

    April 6, 2025

    27

  • Giuseppe Maltese
    @docmaltese (Twitter)

    In adults with type 2 diabetes & increased risk of CV disease, targeting systolic BP <120 mmHg significantly reduces major CV events vs standard <140 mm Hg. Results of a RCT (DOI: 10.1056/NEJMoa2412006) More intensive BP control = better outcomes. Summary
    view full post

    April 6, 2025

    67

    27

  • Shicheng Guo
    @shihcheng.bsky.social (Bluesky)

    Intensive BP control in 50+ yr olds with type 2 diabetes targets <120 mmHg, compared to standard <140 mmHg. Study at 145 sites in China! PMID:39555827, N Engl J Med 2025, @NEJM https://doi.org/10.1056/NEJMoa2412006 #Medsky #Pharmsky #RNA #ASHG #ESHG
    view full post

    April 5, 2025

    7

    1

  • STITCHES Medicine - the Best of Medical Research
    @medicine.stitches.today (Bluesky)

    Intensive blood pressure control in type 2 diabetes patients significantly reduced major cardiovascular events compared to standard treatment. by Bi Y, Li M (...) Wang W et 43 al. in N Engl J Med #MedSky
    view full post

    April 5, 2025

    3

  • STITCHES Medicine - the Best of Medical Research
    @STITCHESMed (Twitter)

    Intensive blood pressure control in type 2 diabetes patients significantly reduced major cardiovascular events compared to standard treatment. by Bi Y, Li M (...) Wang W et 43 al. in N Engl J Med https://t.co/5654RZ8Gex #MedX #MedResearch
    view full post

    April 5, 2025

  • Shicheng Guo
    @ShihchengGuo (Twitter)

    Intensive BP control in 50+ yr olds with type 2 diabetes targets <120 mmHg, compared to standard <140 mmHg. Study at 145 sites in China! PMID:39555827, N Engl J Med 2025, @NEJM https://t.co/zHL2oXEfIv #AI #Pharma #BioMed #RNA #ASHG #ESHG
    view full post

    April 3, 2025

  • Revista MFAndalucia
    @RevistaMFSamfyc (Twitter)

    Control intensivo de la presión arterial en pacientes con diabetes tipo 2 https://t.co/dpu55YVHVi PMID 39555827
    view full post

    April 3, 2025

  • Prof. Nasser Alzerwi
    @NAlzerwi (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    April 1, 2025

    111

  • Andres Felipe Florez
    @Andresffmed (Twitter)

    RT @NEJM: Original Article: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD trial) https://t.co/HrGBjmBr7A Edit…
    view full post

    April 1, 2025

    5

  • Joshua Shirazi, M.S, PA-S2
    @PAJshir95 (Twitter)

    RT @NEJM: Original Article: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD trial) https://t.co/HrGBjmBr7A Edit…
    view full post

    April 1, 2025

    5

  • Juanmarcosgg
    @juanmarcosgg (Twitter)

    RT @NEJM: Original Article: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD trial) https://t.co/HrGBjmBr7A Edit…
    view full post

    April 1, 2025

    5

  • Carmelo Espinosa M.D.
    @carmelografo (Twitter)

    RT @NEJM: Original Article: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD trial) https://t.co/HrGBjmBr7A Edit…
    view full post

    April 1, 2025

    5

  • NEJM
    @NEJM (Twitter)

    Original Article: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes (BPROAD trial) https://t.co/HrGBjmBr7A Editorial: BPROAD — End of the Road for Debate on Systolic Blood-Pressure Goals in Type 2 Diabetes? https://t.co/VG872CvAGg #Cardiology https://t.co/gWWvrrnj3N
    view full post

    April 1, 2025

    26

    5

  • 岩手医科大学 脳神経内科・老年科
    @IwateNeurol (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    April 1, 2025

    111

  • Amith Skandhan MD SFHM FACP
    @ASK_HM17 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    April 1, 2025

    111

  • Dr Mutonkole Jospin
    @JoshMutonkole (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    April 1, 2025

    111

  • María Gabriela Balarezo García MD. MPH. PhD.
    @ma_gabrielab (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    April 1, 2025

    111

  • Marco MF
    @MarcoMF7 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    April 1, 2025

    111

  • Elham Elmehdawi
    @Elham1549664 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    April 1, 2025

    111

  • Andrés Solano
    @AndresSolano (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 31, 2025

    111

  • NEJM.org
    @nejm.org (Bluesky)

    In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-pressure target of less than 120 mm Hg than with a target of less than 140 mm Hg. Full trial results and Research Summary: nej.md/4eyDckd #MedSky #CardioSky
    view full post

    March 31, 2025

    28

    13

  • 弓野大（Dai Yumino）
    @daiyumino (Twitter)

    RT @YHC_Shibuya: 【DrゆみのWeekly Journal Scan】 ＊糖尿病患者の血圧管理　from NEJM＊ https://t.co/pWINe3x1ou 2型糖尿病患者における収縮期血圧の最適管理目標を検討する多施設無作為化比較試験で。中国国内の14…
    view full post

    March 31, 2025

    2

  • Takuya Kishi @ねこ好き循環器内科医
    @tkishi_cardiol (Twitter)

    RT @YHC_Shibuya: 【DrゆみのWeekly Journal Scan】 ＊糖尿病患者の血圧管理　from NEJM＊ https://t.co/pWINe3x1ou 2型糖尿病患者における収縮期血圧の最適管理目標を検討する多施設無作為化比較試験で。中国国内の14…
    view full post

    March 31, 2025

    2

  • 医療法人社団ゆみの
    @yumino_medical (Twitter)

    【DrゆみのWeekly Journal Scan】 ＊糖尿病患者の血圧管理　from NEJM＊ https://t.co/pWINe3x1ou 2型糖尿病患者における収縮期血圧の最適管理目標を検討する多施設無作為化比較試験で。中国国内の145施設で50歳以上の患者12,821名を、目標血圧120 mmHg未満の強化治療群と140
    view full post

    March 31, 2025

    5

    2

  • Dan Beckles
    @DanielBecklesMD (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/O9Sip1v8ia
    view full post

    March 30, 2025

  • Darlynton with a Y
    @MeatIsMeaty (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • EOLO MORANDI JR.
    @eolojr (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • ✮ م ✮ M ✮
    @NotYourFault89 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Ashkan Abdollahi, M.D.
    @aknabdMD (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Ryan N
    @morenaya67 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Xavier Tello, MD
    @StratCons (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Dr. Sou
    @SwissHeartDoc (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Bailey Nelsons
    @Baileybillyb (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Elisa Haas, MD
    @ElisaAHaas (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • El Místico CC
    @Vader_CC (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Dr.Marlon Villanueva™
    @MarlonVFZR (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Maramelia Miranda
    @maramd (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Munya Dimairo
    @mdimairo (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • CardioAcademic
    @CardioAcademic (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • adagajak
    @zftjhust (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Cardio
    @PesarCardio (Twitter)

    درمان فشرده برای کاهش فشار خون سیستولیک به کمتر از ۱۲۰ میلی‌متر جیوه، در بیماران مبتلا به دیابت نوع ۲ به‌طور معنی‌داری خطر بروز حوادث قلبی–عروقی عمده را در مقایسه با درمان استاندارد (هدف کمتر از ۱۴۰ میلی‌متر جیوه) کاهش میده! https://t.co/mRmzNMGxKM
    view full post

    March 30, 2025

    8

  • Enrique Zamora García
    @EzamoraGarc (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Kevin Figueroa, MD
    @kevinfm0931 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • marcus_saemann
    @MarcusSaemann (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Abdelhamid Hamdy
    @abdelhamed012 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Getu Kusa Wakoya, MD
    @Getchk2015 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • พาโรม่า! ft.ผับอัลเกิร์ล III
    @Fame_PE0810 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • ملتقى علوم الاحياء
    @Biology1802 (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Jibril Mohamed
    @jtmohamed (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Nicolas Renna, MD PhD ISHF FESC
    @nicolasrennamd (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Dayas Gurracho
    @BBarsiis (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Guy-Stone, MD, MPH
    @MPH_Stone (Twitter)

    RT @NEJM: In the BPROAD trial, patients with type 2 diabetes had a lower incidence of major cardiovascular outcomes with a systolic blood-p…
    view full post

    March 30, 2025

    111

  • Miguel Turégano
    @tureyedro (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 30, 2025

    55

  • Edgard Pais
    @Edgard_2015 (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/r3lB7zTIK0
    view full post

    March 30, 2025

  • BiigNaJaa
    @BiigNaJaa (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 30, 2025

    55

  • Dr joe_seth
    @joemoyambi2 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 30, 2025

    55

  • Vince Beltran, Ph.D.
    @levin_beltran (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 30, 2025

    55

  • EOLO MORANDI JR.
    @eolojr (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 30, 2025

    55

  • Dr. Shashank Joshi
    @AskDrShashank (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 30, 2025

    55

  • ignacio rs
    @micardirs1 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 30, 2025

    55

  • Dr. Sou
    @SwissHeartDoc (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Lê Văn Lắm
    @levanlam95 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Bongani Mayosi Health Sciences Library (BMHSL)
    @uct_bmhsl (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • reformasi
    @drreformasii (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Nader
    @Nader62321135 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Arun Kr Singh
    @officeaksingh (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Muhammad Naeem
    @naeempunia (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Belgica Tejada
    @belgiTejada (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Dɾ Sααԃ Aʅ Bυɠαɱι. FSCAI د. سعد البقمي
    @bogamisa (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Larissa Eliza
    @larissa_el93050 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Mark Luedde
    @LuddeMark (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Farhad Ariana,MD
    @ariana_farhad (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Mohammed bukhari
    @Moh_bukh (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • PTChC
    @PTChCpl (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Carlos Vergara
    @chiwiperreo_14 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Paulina T
    @PaulinaTrancoso (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • m1Rv
    @elM1RV (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Maryvonne Le Saux-Tallier PhD
    @MLeSaux_Tallier (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Abhishek
    @aksrulz13 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Ebelekur
    @ebelekur (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Brock E. Polnaszek MD MPH(c)
    @BPolnaszek (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • MC
    @atram_8 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Dr. ALCupich
    @alcupich (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Saeed Ahmed
    @Ahmed444Saeed (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Hany Ragy
    @Hragy (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Vietnam Atherosclerosis Society (VAS)
    @HOATRAN82820145 (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes https://t.co/BEUMFiGfMF
    view full post

    March 29, 2025

    1

    1

  • Claudia Guillén-López MD
    @claudiaegl92 (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/x2rdqjvxss
    view full post

    March 29, 2025

    1

  • Kevin Lee
    @CareByKevin (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Lluís masana
    @lluismasana (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Juan Pedro Romero
    @JuanPedroRome20 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Iván_busto
    @ivanbusto82 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Dr.AMiT JAiSWAL
    @aadvikmedics (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Rayees Ahmed Malik
    @imalikrayees (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Carlos Ávila
    @CarlosAR016 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Kananura Keneth
    @kkananura (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Ganesan
    @ganesh48205798 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Mzee
    @mzeengunga (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Ryan N
    @morenaya67 (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • Javi Juega
    @JJuega (Twitter)

    RT @mmacia25: Estudio que confirma la necesidad de ser mas exigente en el control de la HTA en pacientes con DM2. Intensive Blood-Pressure…
    view full post

    March 29, 2025

    15

  • Gauranga Dhar
    @DharGauran4129 (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/PFpdABasrz
    view full post

    March 29, 2025

  • Dr Ashish Kumar
    @DrAshish_Kumar (Twitter)

    RT @MondaEmanuele: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes @NEJM https://t.co/T81xDopUFL https://t.co/AUqmmzBf…
    view full post

    March 29, 2025

    55

  • BaladoCritique : club de lecture médical
    @baladocritique.bsky.social (Bluesky)

    "Intensive Blood-Pressure Control in Patients with Type 2 Diabetes." Publié ce jour dans le @nejm.org. #MedSky #Hypertension www.nejm.org/doi/full/10....
    view full post

    March 27, 2025

  • たけちゃん
    @nitrotake (Twitter)

    BPROAD試験 https://t.co/5TDZNe7KCT https://t.co/JLre17YUAh
    view full post

    March 15, 2025

    3

  • Hiroyuki Sato 佐藤宏行
    @foreverhero0819 (Twitter)

    RT @cardio_tu: 2 min cardiology（臨床、担当：山田祐資） Intensive Blood-Pressure Control in Patients with Type 2 Diabetes Y Bi et al. NEJM Nov 16, 2…
    view full post

    January 31, 2025

    1

  • حسين بن علي الخليفة
    @alkhlifahh (Twitter)

    RT @DRKAMALAYOUB: خفض الضغط الشرياني الانقباضي من ١٤٠ الى ١٢٠ ملم زئبقي لدى الاشخاص المصابين بداء السكري من النوع الثاني ادى الى خفض احتمال…
    view full post

    January 20, 2025

    1

  • الدكتور كمال أيوب
    @DRKAMALAYOUB (Twitter)

    خفض الضغط الشرياني الانقباضي من ١٤٠ الى ١٢٠ ملم زئبقي لدى الاشخاص المصابين بداء السكري من النوع الثاني ادى الى خفض احتمال الاصابة بانسداد شرايين القلب بنسبة ٢١٪ . مما يؤكد ضرورة خفض الضغط الى مستويات طبيعية كل الوقت لدى هذه الفئة من المرضى. https://t.co/2cV9l0UsqS
    view full post

    January 20, 2025

    2

    1

  • 東北大学 循環器内科
    @cardio_tu (Twitter)

    2 min cardiology（臨床、担当：山田祐資） Intensive Blood-Pressure Control in Patients with Type 2 Diabetes Y Bi et al. NEJM Nov 16, 2024 https://t.co/bNaCVPF3hr 2型糖尿病における厳格な血糖コントロール(収縮期血圧 <120mmHg vs <140mmHg)の有効性を示したRCT。 →
    view full post

    January 20, 2025

    1

    1

  • 循環器記事エビデンスメモ
    @3333333fr (Twitter)

    糖尿病でも厳格降圧 https://t.co/sk6IT54EMl
    view full post

    January 19, 2025

  • Aeseerre.....
    @asrzgz1 (Twitter)

    RT @redGDPS: Acceso a publicación en
    view full post

    January 16, 2025

    1

  • Aeseerre.....
    @asrzgz1 (Twitter)

    RT @redGDPS: Full Text links Control intensivo de la presión arterial en pacientes con diabetes tipo 2 | New England Journal of Medicine ht…
    view full post

    January 16, 2025

    1

  • redGDPS Diabetes
    @redGDPS (Twitter)

    Full Text links Control intensivo de la presión arterial en pacientes con diabetes tipo 2 | New England Journal of Medicine https://t.co/AcdI4KikV5
    view full post

    January 16, 2025

    1

  • redGDPS Diabetes
    @redGDPS (Twitter)

    Acceso a publicación en
    view full post

    January 16, 2025

    1

  • おちば@腎臓内科
    @autumnleaveskid (Twitter)

    【BPROAD試験】読んだ! ★50歳以上のT2DM+高血圧+CVDリスクがある12821人 ★sBP120mmHg未満目標vs140mmHg未満目標 ★心血管イベントは1.65/100人年vs2.09/100人年でHR0.79 ★SPRINT試験同様、血圧はきっちり下げるべきかも …個人的にCKD患者はあんまりいなかったのが残念
    view full post

    January 14, 2025

    5

  • Nephrology Journal Club
    @NephJC (Twitter)

    2/10 What'd I miss? ❗⏫BP
    view full post

    December 16, 2024

    2

  • Nephrology Journal Club
    @nephjc.bsky.social (Bluesky)

    2/10 What'd I miss? ❗⏫BP more
    view full post

    December 16, 2024

    2

    1

  • ACCP Cardiology PRN
    @accpcardprn (Twitter)

    The debate of strict versus lenient blood pressure control continues with more data supporting the former just published. Read the full text of the BROAD trial in #NEJM below. https://t.co/60bTFZvnLh
    view full post

    December 12, 2024

  • Roberto Gutiérrez
    @DrRobertoGuti (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 5, 2024

    16

  • M Azfar Qureshi
    @MAQ_Renal (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 4, 2024

    16

  • Angelie, MD
    @AeonTam (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 4, 2024

    16

  • NephroLOGY BOX. GUO's
    @ulusalokyay (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 4, 2024

    16

  • Kananura Keneth
    @kkananura (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 4, 2024

    16

  • DrMugeloveskidneys
    @smuge2 (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 3, 2024

    16

  • shaffy
    @shaffy8585 (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 3, 2024

    16

  • Wisit Cheungpasitporn MD FACP | FASN | FAST
    @wisit661 (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 3, 2024

    16

  • UK
    @Iamuksingh (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 3, 2024

    16

  • Niranjan Ganesh
    @Drniran (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 3, 2024

    16

  • Dr Theepa N.M.R
    @TNesam (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 3, 2024

    16

  • Ye M. Tun, MD FACP
    @DrYeMyintTun (Twitter)

    RT @edgarvlermamd: BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120…
    view full post

    December 3, 2024

    16

  • Edgar V. Lerma
    @edgarvlermamd (Twitter)

    BPROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120 mm Hg than w/ standard treatment targeting SBP < 140 mm Hg #Nephpearls #NephJC #VisualAbstract by @KajareeG
    view full post

    December 3, 2024

    40

    16

  • soda_troubles,https://med-mastodon.com/@haysam
    @set_fortess (Twitter)

    RT @edgarvlermamd: BROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120 m…
    view full post

    December 3, 2024

    2

  • Marilena Roumelioti
    @MRoumelioti (Twitter)

    RT @edgarvlermamd: BROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120 m…
    view full post

    December 3, 2024

    2

  • Edgar V. Lerma
    @edgarvlermamd.bsky.social (Bluesky)

    BROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120 mm Hg than w/ standard treatment targeting SBP < 140 mm Hg #Nephpearls #NephJC #VisualAbstract by @kajareeg.bsky.social
    view full post

    December 3, 2024

    8

    1

  • Edgar V. Lerma
    @edgarvlermamd (Twitter)

    BROAD: Among patients w/ T2D, the incidence of MACE was significantly lower w/ intensive treatment targeting SBP < 120 mm Hg than w/ standard treatment targeting SBP < 140 mm Hg #Nephpearls #NephJC #VisualAbstract by @KajareeG
    view full post

    December 3, 2024

    4

    2

  • Carmen De Miguel, PhD, MS, FAHA
    @Carmendemigue12 (Twitter)

    RT @CajinaCarmen: Intensive Blood-Pressure Control in Patients with Type 2 Diabetes - PubMed https://t.co/NCw6WLBRfq
    view full post

    December 3, 2024

    1

  • Carmen Cajina
    @CajinaCarmen (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes - PubMed https://t.co/NCw6WLBRfq
    view full post

    December 3, 2024

    3

    1

  • Hernandez Edgar
    @Internistacl (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | New England Journal of Medicine https://t.co/KPbMsYqoam
    view full post

    December 3, 2024

  • JorgeEdoChava75
    @QicenoJorge (Twitter)

    RT @redGDPS:
    view full post

    November 28, 2024

    22

  • Miguel Turégano
    @tureyedro (Twitter)

    RT @redGDPS:
    view full post

    November 28, 2024

    22

  • Paolo Cabeza Martínez
    @paolo_cabeza (Twitter)

    RT @redGDPS:
    view full post

    November 28, 2024

    22

  • SEMERGEN Murcia
    @SEMERGENMurcia (Twitter)

    RT @redGDPS:
    view full post

    November 28, 2024

    22

  • Carol
    @Carolo9225 (Twitter)

    RT @redGDPS:
    view full post

    November 27, 2024

    22

  • Lilia Andrea
    @LiliaAndreataf1 (Twitter)

    RT @redGDPS:
    view full post

    November 27, 2024

    22

  • David
    @davmdz (Twitter)

    RT @redGDPS:
    view full post

    November 27, 2024

    22

  • Revista MFAndalucia
    @RevistaMFSamfyc (Twitter)

    Control intensivo de la presión arterial en pacientes con diabetes tipo 2 https://t.co/VGeriT3nDo PMID 39555827
    view full post

    November 27, 2024

  • @Hombre lobo
    @juanito72880151 (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Elisabet Bertran Mazón
    @bertraneli (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Daniel Gïlæ
    @DGLopez8 (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Carlos Hdez Teixidó
    @carlos_teixi (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Carliitoos43
    @Carliitoos90 (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Podoscopio Science
    @PodologiaMexico (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Fco Carramiñana Barrera
    @fcbzafra (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Roberto Gutiérrez
    @DrRobertoGuti (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Linternista
    @Linternistas (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Dr. Omar Meza
    @OmarMeza1501 (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • Eduardo
    @Eduardo42937195 (Twitter)

    RT @redGDPS:
    view full post

    November 26, 2024

    22

  • redGDPS Diabetes
    @redGDPS (Twitter)


    view full post

    November 26, 2024

    60

    22

  • STITCHES Medicine - the Best of Medical Research
    @STITCHESMed (Twitter)

    Intensive blood-pressure control in type 2 diabetes patients significantly reduced major cardiovascular events compared to standard treatment. by Bi Y, Li M (...) Dong Q et 5 al. in N Engl J Med https://t.co/5654RZ9e45
    view full post

    November 25, 2024

  • pinacol
    @pinacol (Twitter)

    【RCT】収縮期血圧が高く、心血管リスクが高い50歳以上の2型糖尿病患者での厳格な降圧（120mmHg未満）は、標準的な降圧（140mmHg未満）と比較して、非致死性脳卒中、非致死性心筋梗塞、心不全の治療または入院、心血管死亡の複合転帰リスクを減少させた。 #ペ読 https://t.co/tOmbkyIKOG
    view full post

    November 24, 2024

    1

  • にいやん
    @niiyan51 (Twitter)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes https://t.co/lzFjmNkeE8
    view full post

    November 23, 2024

  • KManter, MD
    @kmantermd.bsky.social (Bluesky)

    Intensive Blood-Pressure Control in Patients with Type 2 #Diabetes www.nejm.org/doi/full/10.... Among patients with DM, the incidence of major CV events was significantly lower with intensive tx targeting a SBP <120 than with standard tx targeting a SBP of <140 mm Hg. #MedSky #PrimaryCare
    view full post

    November 22, 2024

    5

    4

  • 田中”ストラトス”雅楽頭
    @lancia12 (Twitter)

    RT @EARL_med_tw:
    view full post

    November 18, 2024

    1

  • EARLの医学&AIノート
    @EARL_med_tw (Twitter)


    view full post

    November 18, 2024

    4

    1

  • Abdulla A. Damluji, MD, PhD, MBA
    @drdamluji.bsky.social (Bluesky)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes: @NEJM
    view full post

    November 18, 2024

    2

    2

  • Leora Horwitz
    @leorahorwitzmd.bsky.social (Bluesky)

    So much evidence now that SBP targets should be lower than we used to think necessary. ACCORD in same pop wasn’t significant but smaller; SPRINT in people without diabetes similar results as here; also benefits for dementia (SPRINT MIND). #MedSky https://www.nejm.org/doi/full/10.1056/NEJMoa2412006
    view full post

    November 17, 2024

    3

    1

  • Parham Eshtehardi MD
    @cardioobdoc.bsky.social (Bluesky)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes #BPROAD www.nejm.org/doi/full/10.... #NEJM #AHA24 #CardioSky #Hypertension #MedSky @ahascience.bsky.social @dramitkhera.bsky.social
    view full post

    November 16, 2024

    19

    11

  • Boback Ziaeian
    @boback.bsky.social (Bluesky)

    Intensive Blood-Pressure Control in Patients with Type 2 Diabetes www.nejm.org/doi/full/10....
    view full post

    November 16, 2024

    4

    3

Abstract Synopsis

  • A study was conducted to find out the best systolic blood pressure targets for patients over 50 with type 2 diabetes and high cardiovascular risk, comparing intensive treatment (target <120 mm Hg) to standard treatment (target <140 mm Hg) over 5 years.
  • Out of 12,821 patients, the intensive treatment group had a lower average systolic blood pressure after one year (121.6 mm Hg) compared to the standard group (133.2 mm Hg), resulting in significantly fewer major cardiovascular events.
  • Despite the lower overall events in the intensive group, there were more cases of symptomatic hypotension and hyperkalemia, but the rates of serious adverse events were similar in both groups.